MediciNova, Inc. (MNOV)
NASDAQ: MNOV · Real-Time Price · USD
1.395
-0.005 (-0.36%)
At close: Nov 13, 2026, 4:00 PM EST
1.390
-0.005 (-0.36%)
After-hours: Nov 13, 2026, 4:15 PM EST
MediciNova Market Cap
MediciNova has a market cap or net worth of $68.66 million as of November 13, 2026. It is the 27,622nd most valuable company in the world and the 4,339th biggest in the United States. Its market cap has decreased by 10.83% in one year.
Market Cap
68.66M
Enterprise Value
39.51M
1-Year Change
-10.83%
Global Rank
Country Rank
#4,339 United States
Category
ChartMarket Cap Chart
Since December 8, 2006, MediciNova's market cap has decreased from $124.80M to $68.66M, a decrease of -44.98%. That is a compound annual growth rate of -2.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 71.50M | 11.20% |
| Dec 31, 2025 | 64.30M | -37.57% |
| Dec 31, 2024 | 103.00M | 39.95% |
| Dec 29, 2023 | 73.60M | -26.77% |
| Dec 30, 2022 | 100.50M | -23.52% |
| Dec 31, 2021 | 131.40M | -44.39% |
| Dec 31, 2020 | 236.30M | -20.03% |
| Dec 31, 2019 | 295.50M | -13.65% |
| Dec 31, 2018 | 342.20M | 46.49% |
| Dec 29, 2017 | 233.60M | 12.31% |
| Dec 30, 2016 | 208.00M | 95.67% |
| Dec 31, 2015 | 106.30M | 44.43% |
| Dec 31, 2014 | 73.60M | 53.65% |
| Dec 31, 2013 | 47.90M | 69.86% |
| Dec 31, 2012 | 28.20M | 3.30% |
| Dec 30, 2011 | 27.30M | -53.41% |
| Dec 31, 2010 | 58.60M | -31.22% |
| Dec 31, 2009 | 85.20M | 346.07% |
| Dec 31, 2008 | 19.10M | -65.27% |
| Dec 31, 2007 | 55.00M | -59.85% |
| Dec 29, 2006 | 137.00M | 9.78% |
| Dec 8, 2006 | 124.80M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OKYO Pharma | 74.52M |
| PDS Biotechnology | 73.92M |
| Nutriband | 72.20M |
| Gossamer Bio | 71.50M |
| Conexeu Sciences | 69.68M |
| Heron Therapeutics | 68.37M |
| Cingulate | 67.47M |
| Acrivon Therapeutics | 67.28M |